Skip to main content
Premium Trial:

Request an Annual Quote

BD Acquires Cell Sorting Instrument Firm

NEW YORK (GenomeWeb News) – Becton Dickinson said last night that it has acquired all of the outstanding stock of privately held Cytopeia, which makes advanced flow cytometry cell sorting instruments.
 
BD did not disclose financial terms of the acquisition but said that is not expected to have a material impact on the firm’s 2008 earnings.
 
Franklin Lakes, NJ-based BD said that Cytopeia’s Influx cell sorter provides the firm with an open, configurable cell sorting platform that can be fully optimized for application-specific requirements. It said the Influx could be used in cell therapy research, stem cell research, drug discovery and development, and marine biology applications and is complementary to its FACSAria II system.
 
Seattle-based Cytopeia was the first spin-off from the Institute for Systems Biology.
 
Cytopeia President and Chief Technology Officer Ger van den Engh will join BD Biosciences as VP of Advanced Cytometry and continue research and technology development activities in Seattle, said BD.
 

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.